SEARCH

SEARCH BY CITATION

Keywords:

  • multiple sclerosis;
  • MS treatment;
  • immuno-suppressive drugs;
  • immunomodulatory drugs;
  • MS clinical trials;
  • peptides;
  • altered peptide ligand

Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system. Numerous treatment options are available to MS patients; however, these options need to be improved. Herein, we review the current drugs and therapeutic approaches available to MS patients, preclinical trial interventions and recent animal model studies for the potential therapy of MS. Since the current treatment of MS remains elusive and is limited, animal studies and clinical research offers an optimistic outlook.